HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever Sales Adjusted for Top Brands As Trade Destocking Hits HPC In Q2

This article was originally published in The Rose Sheet

Executive Summary

Unilever expects sales of its leading 400 brands to be up 4% in 2003 compared to previously projected growth of 5%-6%, VP-Investor Relations Howard Green reported during a June 23 second quarter pre-close call. Final results are scheduled for July 30

You may also be interested in...



Unilever Personal Care Sales Advance 4% In Q2, Boosted By Core Brands

Unilever's personal care business advanced 4% to $3.59 bil. (€1=$1.14) in the second quarter at constant exchange rates on the strong performance of leading brands in hair care, skin care and deodorants, the company announced July 30

Unilever Personal Care Sales Advance 4% In Q2, Boosted By Core Brands

Unilever's personal care business advanced 4% to $3.59 bil. (€1=$1.14) in the second quarter at constant exchange rates on the strong performance of leading brands in hair care, skin care and deodorants, the company announced July 30

Unilever To Focus Resources On 400 "Core Brands"

Unilever plans to cut its worldwide product stable of 1,600 brands to a core portfolio of approximately 400 leading brands that are "number one or number two in their market or segment" and have "worldwide market reach," the company said. The personal care products, food and household giant presented its strategy to investors at conferences in London, Rotterdam and New York City the week of Sept. 20.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011329

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel